These ASX shares can rise 25% to 100%+

Analysts think these shares could deliver big returns for investors.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Are you looking for big returns for your investment portfolio?

If you are, then take a look at the three ASX shares listed below that have been tipped to rise materially by analysts.

Here's what you need to know about them:

A man looks surprised as a woman whispers in his ear.

Image source: Getty Images

AVITA Medical Inc (ASX: AVH)

Morgans sees huge upside for this ASX share over the next 12 months. In fact, the broker believes the regenerative medicine company could more than double in value from current levels.

It was very pleased with news that the US FDA has approved its Recell Go product. It is an autologous cell harvesting device, harnessing the regenerative properties of a patient's own skin to treat burn wounds and full-thickness skin defects. It commented:

AVH has received FDA approval for its automated product, RECELL Go, for use in burns and full thickness skin defects. This approval marks a significant milestone for the company, with management expecting this device to increase adoption of the technology amongst clinicians. We have made no changes to our forecasts and recommendation.

Morgans has an add rating and $6.40 price target on its shares. This implies potential upside of 115% for investors.

Champion Iron Ltd (ASX: CIA)

Analysts at Goldman Sachs think that this miner would be a great option for investors that are looking for exposure to iron ore. The broker feels its shares are undervalued at the current level and could offer major upside potential and good dividend yields. It said:

Supportive Valuation: the stock is trading at 0.8x NAV (A$8.8/sh) and ~4.4x EBITDA (NTM). Our NAV is based on a long run Fe price of ~US$105/t (real) for 65% Fe and ~US$75/t premium for DRPF above 62% Fe Index. For every ~US$10/t increase in our long run price, our CIA NAV would increase by ~A$1.5/sh.

Goldman has a buy rating and $8.80 price target on its shares. This implies potential upside of 25% for investors. In addition, it is forecasting dividend yields of 4% in FY 2025 and 6% in FY 2026.

Eagers Automotive Ltd (ASX: APE)

Another ASX share that could offer big returns is Eagers Automative. It operates one of Australia's largest auto dealership networks.

Bell Potter thinks that the company's shares have been oversold following a disappointing trading update last month. It said:

We believe this is a relatively isolated event that doesn't materially change the outlook so our investment thesis remains intact. We believe the stock looks value on a 2025 PE ratio of c.10x and a forecast yield of c.6% in 2024 and c.7% in 2025.

Its analysts have a buy rating and $13.35 price target on its shares. This implies potential upside of 32% for investors. In addition, dividend yields of 6%+ are forecast through to FY 2026.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Avita Medical and Goldman Sachs Group. The Motley Fool Australia has recommended Avita Medical and Eagers Automotive Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

A woman holds her finger to the side of her face and looks upwards as she thinks about something.
Broker Notes

4 ASX shares at 52-week lows: Buy, hold, or sell?

Here's what the experts think.

Read more »

A female athlete in green spandex leaps from one cliff edge to another representing 3 ASX shares that are destined to rise and be great
Broker Notes

Up 57% since February, why Telix shares could keep leaping higher in 2026

A leading analyst believes investors are undervaluing Telix shares. But why?

Read more »

A happy young woman in a red t-shirt hold up two delicious burritos.
Broker Notes

Guzman Y Gomez shares just sank to new all-time lows. Time to buy?

A leading analyst provides his outlook for the battered Guzman Y Gomez share price.

Read more »

An oil refinery worker stands in front of an oil rig with his arms crossed and a smile on his face.
Energy Shares

4 ASX 200 energy shares rated buys

ASX 200 energy shares have skyrocketed 14% over the past month.

Read more »

A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.
Broker Notes

Buy, hold, sell: BHP, CBA, and Pro Medicus shares

Are analysts bullish on the big names? Let's find out.

Read more »